Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
2002-7-3
pubmed:abstractText
There is growing interest in the potential health benefits of tea, including the anticarcinogenic properties. We report here that white tea, the least processed form of tea, is a potent inhibitor of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced colonic aberrant crypts in the rat. Male Fischer 344 rats were treated for 8 wk with white tea (2% wt/vol) or drinking water alone, and on alternating days in experimental Weeks 3 and 4 the animals were given PhIP (150 mg/kg body wt p.o.) or vehicle alone. At the end of the study there were 5.65 +/- 0.81 and 1.31 +/- 0.27 (SD) aberrant crypt foci per colon in groups given PhIP and PhIP + white tea, respectively (n = 12, P < 0.05). No changes were detected in N-acetyltransferase or arylsulfotransferase activities compared with controls, but there was marked induction of ethoxyresorufin O-deethylase, methoxyresorufin O-demethylase, and UDP-glucuronosyltransferase after treatment with white tea. Western blot revealed corresponding increases in cytochrome P-450 1A1 and 1A2 proteins. Enzyme assays and Western blot also revealed induction of glutathione S-transferase by white tea. There was less parent compound and 4'-hydroxy-PhIP but more PhIP-4'-O-glucuronide and PhIP-4'-O-sulfate in the urine from rats given PhIP + white tea than in urine from animals given carcinogen + drinking water. The results indicate that white tea inhibits PhIP-induced aberrant crypt foci by altering the expression of carcinogen-metabolizing enzymes, such that there is increased ring hydroxylation at the 4' position coupled with enhanced phase 2 conjugation.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-10333533, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-10363577, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-10368809, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-10503909, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-10590222, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-10630599, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-10706103, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-10721932, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-11196146, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-11196148, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-11228277, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-11448643, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-1394832, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-3677050, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-7554067, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-7727039, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-8603466, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-8603484, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-8690310, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-8706244, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-9126728, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-9202752, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-9205068, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-9447274, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-9447275, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-9737435, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-9751618, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094635-9892181
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/2-amino-1-methyl-6-phenylimidazo(4,5..., http://linkedlifedata.com/resource/pubmed/chemical/Anticarcinogenic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 CYP1A1, http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 CYP1A2, http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 Enzyme System, http://linkedlifedata.com/resource/pubmed/chemical/Glucuronides, http://linkedlifedata.com/resource/pubmed/chemical/Glucuronosyltransferase, http://linkedlifedata.com/resource/pubmed/chemical/Glutathione Transferase, http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Oxidoreductases, http://linkedlifedata.com/resource/pubmed/chemical/Sulfates, http://linkedlifedata.com/resource/pubmed/chemical/Tea, http://linkedlifedata.com/resource/pubmed/chemical/methoxyresorufin-O-demethylase
pubmed:status
MEDLINE
pubmed:issn
0163-5581
pubmed:author
pubmed:issnType
Print
pubmed:volume
41
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
98-103
pubmed:dateRevised
2011-9-26
pubmed:meshHeading
pubmed-meshheading:12094635-Animals, pubmed-meshheading:12094635-Anticarcinogenic Agents, pubmed-meshheading:12094635-Colon, pubmed-meshheading:12094635-Colonic Neoplasms, pubmed-meshheading:12094635-Cytochrome P-450 CYP1A1, pubmed-meshheading:12094635-Cytochrome P-450 CYP1A2, pubmed-meshheading:12094635-Cytochrome P-450 Enzyme System, pubmed-meshheading:12094635-Enzyme Induction, pubmed-meshheading:12094635-Glucuronides, pubmed-meshheading:12094635-Glucuronosyltransferase, pubmed-meshheading:12094635-Glutathione Transferase, pubmed-meshheading:12094635-Imidazoles, pubmed-meshheading:12094635-Male, pubmed-meshheading:12094635-Oxidoreductases, pubmed-meshheading:12094635-Precancerous Conditions, pubmed-meshheading:12094635-Rats, pubmed-meshheading:12094635-Rats, Inbred F344, pubmed-meshheading:12094635-Sulfates, pubmed-meshheading:12094635-Tea
pubmed:year
2001
More...